ITOEF yields 1.64% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, ITOEF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ITOEF + JNJ for your $10,000?
Ito En, Ltd. manufactures and sells green tea beverages in Japan and internationally. The company provides Japanese tea, black tea, and Chinese tea; coffee beverages; fruit, vegetable, and other beverages; and tea leaves, as well as yoghurt, milk, and other dairy products. It also manages eateries; and develops franchise chain store system. The company offers its products through convenience stores, supermarkets, general and mass retailers, vending machines, station stores, and other channels. The company primarily operates under the Oi Ocha, TULLY's COFFEE, and MATCHA GREEN TEA brands. It operates 112 specialty tea shops at locations, such as department stores, shopping malls, and airports in Japan. The company was formerly known as Frontier Tea Corporation and changed its name to Ito En, Ltd. in May 1969. Ito En, Ltd. was founded in 1964 and is headquartered in Tokyo, Japan.
Full ITOEF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.